DaunorubicinEpirubicinAntibiotics, AntineoplasticNaphthacenesAntineoplastic Combined Chemotherapy ProtocolsCytarabineAnthracyclinesDoxorubicinRazoxaneIdarubicinP-GlycoproteinCyclophosphamideBreast NeoplasmsFluorouracilDrug Resistance, MultipleDrug Administration ScheduleVerapamilLeukemia, Myeloid, AcuteLeukemia P388TaxoidsPaclitaxelMitoxantroneRemission InductionDrug ResistanceChemotherapy, AdjuvantTreatment OutcomeThioguanineVincristineDrug Resistance, NeoplasmAntineoplastic AgentsDisease-Free SurvivalDose-Response Relationship, DrugCisplatinVinblastineCyclosporinsAclarubicinCarcinoma, Ehrlich TumorEtoposideInfusions, IntravenousLeukemia, MyeloidSurvival AnalysisMethotrexateNeoadjuvant TherapyStreptomycesNeutropeniaGranulocyte Colony-Stimulating FactorDeoxycytidineSurvival RateLiposomesBenzylisoquinolinesTumor Cells, CulturedAsparaginaseAlopeciaHL-60 CellsDrug Screening Assays, AntitumorPyrazolonesAnthraquinonesHeart DiseasesProlyl HydroxylasesDrug AgonismConsolidation ChemotherapyK562 CellsGenes, MDRIfosfamideHematologic DiseasesMultidrug Resistance-Associated ProteinsRhodamine 123Combined Modality TherapyDrug InteractionsDrug SynergismStomach NeoplasmsCell SurvivalNeoplasm MetastasisNeoplasm StagingAntineoplastic Agents, PhytogenicTopoisomerase II InhibitorsLeukemia, ExperimentalAcute DiseaseLeukopeniaLeukemiaSilicon Compounds